These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3083214)

  • 1. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
    Fritzler MJ
    Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methods for determining antinuclear antibodies and their clinical significance].
    Aeschlimann A; Meyer O; Kahn MF; Müller W
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on laboratory studies and relationship to rheumatic and allergic diseases.
    McCarty GA
    Ann Allergy; 1985 Sep; 55(3):421-33. PubMed ID: 2412470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
    Haberhauer G; Bröll H
    Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoserological area--with special reference to the current topics on antinuclear antibodies].
    Moteki S; Yoshida H
    Rinsho Byori; 1990 Jul; 38(7):765-72. PubMed ID: 2205741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.
    Cohen MG; Pollard KM; Schrieber L
    Clin Exp Immunol; 1988 Apr; 72(1):50-4. PubMed ID: 3260838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
    Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
    Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of tests for antinuclear antibodies (ANA) in rheumatic diseases.
    Nakamura RN; Tan EM
    West J Med; 1978 Jan; 128(1):51-2. PubMed ID: 415436
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory diagnosis of systemic rheumatic disease.
    Maehara KT
    Am J Med Technol; 1983 Jul; 49(7):477-81. PubMed ID: 6194686
    [No Abstract]   [Full Text] [Related]  

  • 15. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
    Deng JS; Bair LW; Medsger TA; Sontheimer RA
    Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of antinuclear antibodies in rheumatic diseases].
    Endresen GK; Mellbye OJ
    Tidsskr Nor Laegeforen; 1991 Feb; 111(6):716-9. PubMed ID: 2008695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.
    Tan EM; Smolen JS; McDougal JS; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wiik A; Wilson M; Koziol JA
    J Rheumatol; 2002 Jan; 29(1):68-74. PubMed ID: 11824974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against soluble nuclear antigens in rheumatic diseases].
    Nikolov K; Baleva M
    Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.